Myopine is the world’s first low-dose atropine eye drop formulation with preservatives, officially registered with an approved indication for controlling the progression of myopia in children from aged 6 years and older. https://ova.galencentre.org/protecting-growing-eyes-idb-visioncare-launches-myopineeye-drops-in-malaysia-to-combat-rising-myopia-in-children/